Your browser doesn't support javascript.
loading
Beyond the Androgen Receptor: The Sequence, the Mutants, and New Avengers in the Treatment of Castrate-Resistant Metastatic Prostate Cancer.
Westaby, Daniel; Viscuse, Paul V; Ravilla, Rahul; de la Maza, Maria de Los Dolores Fenor; Hahn, Andrew; Sharp, Adam; de Bono, Johann; Aparicio, Ana; Fleming, Mark T.
Afiliação
  • Westaby D; The Institute of Cancer Research and The Royal Marsden Hospital, London, United Kingdom.
  • Viscuse PV; Division of Cancer Medicine, University of Texas MD Anderson Cancer Center, Houston, TX.
  • Ravilla R; US Oncology Research, New York Oncology Hematology, Albany, NY.
  • de la Maza MLDF; The Institute of Cancer Research and The Royal Marsden Hospital, London, United Kingdom.
  • Hahn A; Division of Cancer Medicine, University of Texas MD Anderson Cancer Center, Houston, TX.
  • Sharp A; The Institute of Cancer Research and The Royal Marsden Hospital, London, United Kingdom.
  • de Bono J; The Institute of Cancer Research and The Royal Marsden Hospital, London, United Kingdom.
  • Aparicio A; Department of Genitourinary Medical Oncology, University of Texas MD Anderson Cancer Center, Houston, TX.
  • Fleming MT; US Oncology Research, Virginia Oncology Associates, Norfolk, VA.
Am Soc Clin Oncol Educ Book ; 41: e190-e202, 2021 Jun.
Article em En | MEDLINE | ID: mdl-34061561

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias de Próstata Resistentes à Castração Tipo de estudo: Prognostic_studies Limite: Humans / Male Idioma: En Revista: Am Soc Clin Oncol Educ Book Ano de publicação: 2021 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias de Próstata Resistentes à Castração Tipo de estudo: Prognostic_studies Limite: Humans / Male Idioma: En Revista: Am Soc Clin Oncol Educ Book Ano de publicação: 2021 Tipo de documento: Article